WELCOME TO THE NAPPI RESEARCH GROUP

In Nappi Research Group innovation meets compassion in the fight against cancer. Led by Dr. Nappi (MD. PhD.), a medical oncologist and clinician scientist, our team is dedicated to advancing cancer research. Situated within the esteemed Vancouver Prostate Centre and affiliated with the University of British Columbia’s Department of Urologic Sciences, we strive to unravel the complexities of cancer biology. With a focus on translational research, we work to bridge the gap between scientific discovery and clinical application. Through collaboration, dedication, and a patient-centered approach, Nappi Research Group is committed to making meaningful strides in cancer care. Join us on our journey to transform the landscape of oncology and improve outcomes for patients worldwide.

RESEARCH

Our research focuses on the diagnosis and treatment of Testicular, prostate, and kidney cancer through clinical trials, translational studies, and innovative approaches.

Testicular Cancer

Conducting clinical trials to study miRNA’s in patient with germ cell tumors, translational studies, and developing cutting-edge nanobiosensors for early diagnosis.

Prostate Cancer

Discovering novel treatments through clinical trials and translating research findings for improved prostate cancer treatment outcomes.

Kidney Cancer

Exploring innovative immunotherapy and biomarker discovery approaches to revolutionize kidney cancer treatment and diagnosis.